Search results (844)
« Back to NewsOxford to advance mental health research through £1.5 million gift
10 February 2026
The University of Oxford has received a £1.5 million gift from Bukhman Philanthropies to support new research aiming to tackle one of the most pressing challenges of our time – young people’s mental health.
The Oxford-Harrington Rare Disease Centre advances discovery of therapies for Friedreich’s Ataxia (FA)
9 February 2026
Philanthropic funding from the Friedreich's Ataxia Alliance Innovation Fund awarded to five Oxford researchers to support development of novel therapeutics.
Public trust in health data sharing for AI is conditional
9 February 2026
Public support for sharing health data for artificial intelligence (AI) research depends on clear public benefit, strong safeguards, and meaningful consent, according to a new Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) study based on in-depth focus groups with members of the UK public.
The changing face of heart disease: Why it’s time to rethink prevention
9 February 2026
For decades, heart disease prevention has been one of the biggest public health success stories. Thanks to research and better awareness about risks like high blood pressure, smoking, and cholesterol, rates of heart attacks and strokes have fallen dramatically since the 1960s. But in recent years, this progress has slowed, and in some countries, even reversed.
Statins do not cause the majority of side effects listed in package leaflets
6 February 2026
Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, depression, sleep disturbance, and erectile and sexual dysfunction, according to the most comprehensive review of possible side effects. The study was led by researchers at the Nuffield Department of Population Health and published in The Lancet.
New Oxford-led initiative launches to train future leaders in transformative technologies for pharmaceutical research
5 February 2026
GSK, in partnership with the Universities of Oxford, Cambridge and Southampton, has launched Transformative Technologies in Pharmaceutical Sciences (TTPS). This cross-sector doctoral training programme will equip a new generation of researchers to translate basic scientific research and biological understanding into novel technologies, vaccines, therapies and drugs that will accelerate patient benefit. The new programme is a part of the Industrial Landscape Award programme announced by BBSRC.
New Oxford-led trial explores if the immune system can be trained to control HIV
4 February 2026
Can the immune system be trained to control HIV without continuous medication? A new Oxford-led clinical trial is exploring whether immune-based strategies could support longer-term viral control after stopping antiretroviral therapy.
Sleep apnoea: not just an airway problem but an exemplar of a systems-medicine complex disorder
4 February 2026
Obstructive sleep apnoea is one of the most common conditions occurring in sleep medicine, traditionally understood as a mechanical problem: during sleep, the upper airway is obstructed, interrupting breathing and oxygen supply. Treatments have largely focused on this anatomy, particularly through continuous positive airway pressure (CPAP) therapy.
Treatment of tumours with sound: New high-intensity focused ultrasound machine installed
2 February 2026
A new state-of-the-art high-intensity focused ultrasound (HIFU) machine has been installed at the Churchill Hospital, giving Oxford University Hospitals (OUH) cancer patients access to the latest in this innovative technology.
Long-overlooked cerebral cortical cell layer may hold key to attention
2 February 2026
Berlin and Oxford collaborative researchers funded by Einstein Foundation propose a new circuit theory linking a little-known cortical layer to attention and brain disorders.
National Perinatal Epidemiology Unit officially joins the Nuffield Department of Women’s & Reproductive Health
2 February 2026
The University of Oxford is pleased to announce that, as of Monday 2 February, the National Perinatal Epidemiology Unit (NPEU) has officially joined the Nuffield Department of Women’s & Reproductive Health (NDWRH). This marks a significant milestone in a partnership first announced in 2025 and represents a major strategic step in strengthening Oxford’s leadership in women’s, maternal and reproductive health research and education.
Oxford spinout launches AI-based ultrasound technology to improve early detection of pregnancy complications
2 February 2026
A new University of Oxford spinout, Oxailis Ltd, has launched an AI-based ultrasound technology that enables healthcare professionals to measure perfusion (how effectively oxygen-rich blood is delivered to tissue), using existing standard ultrasound hardware and without the need for contrast agents.
Study tests whether deep brain stimulation can treat chronic pain
2 February 2026
A research study by Oxford neurosurgeons and engineers is trialling whether deep brain stimulation (DBS) – delivering an electrical pulse into affected areas of the brain – can help to relieve central post-stroke pain (CPSP).
Who gets menopause treatment – and who is left out?
30 January 2026
Hormone replacement therapy (HRT) is one of the most effective treatments for menopausal symptoms, yet a major new international study led by researchers from the Nuffield Department of Primary Care Health Sciences suggests that access to it is far from equal.
A step forward for ankle fracture management
29 January 2026
In an editorial piece published in The BMJ, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Professors David Keene and Matthew Costa commend a new clinical trial that advances the understanding of ankle fracture treatment.
New clinical study launched examining the role of insulin in breast cancer treatment response
28 January 2026
A new clinical study has launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
Kennedy scientists join world-leading researchers in ‘pivotal’ study to help arthritis patients to live drug free
27 January 2026
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration.
Reducing salt in everyday foods could prevent tens of thousands of heart attacks and strokes, new study finds
26 January 2026
A new study led by researchers in the Nuffield Department of Primary Care Health Sciences has found that if the UK food industry had met the government’s voluntary 2024 salt reduction targets, substantial improvements could have been made in cardiovascular health, leading to major savings for the NHS - all without the public having to change their eating habits.
Rapamycin helps protect immune cells against DNA damage
26 January 2026
New research carried out by Dr Loren Kell at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) has demonstrated for the first time that rapamycin can reduce DNA damage in immune cells, a hallmark of ageing.
Convoluted systems block access to GP appointments
23 January 2026
Centrally imposed systems for booking GP appointments and the effort needed to keep them working to improve access for patients is having the opposite effect, according to new research led by the Universities of Oxford and Southampton.